Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen J Lachmann

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Best Practice & Research. Clinical Rheumatology|May 19, 2018
Periodic fever syndromesHelen J Lachmann
Journal of the American Society of Nephrology : JASN|May 15, 2024
Advancing Care for AA Amyloidosis with Biomarker-Based StagingHelen J Lachmann
Clinical Medicine (London, England)|June 3, 2015
Autoinflammatory syndromes as causes of fever of unknown originHelen J Lachmann
The New England Journal of Medicine|August 30, 2013
A new era in the treatment of amyloidosis?Helen J Lachmann
Current Allergy and Asthma Reports|July 6, 2011
The emerging role of interleukin-1β in autoinflammatory diseasesThirusha Lane, Helen J Lachmann
Clinical and Experimental Rheumatology|December 3, 2016
Reply to: Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis. Dinoia et alThirusha Lane, Helen J Lachmann
Rheumatic Diseases Clinics of North America|October 3, 2018
Secondary, AA, AmyloidosisRiccardo Papa, Helen J Lachmann
Turkish Journal of Medical Sciences|August 19, 2020
Familial Mediterranean fever, from pathogenesis to treatment: a contemporary reviewAbdurrahman Tufan, Helen J Lachmann
Current Opinion in Pharmacology|February 18, 2006
Systemic amyloidosisHelen J Lachmann, Philip N Hawkins
Nature Reviews. Rheumatology|April 26, 2016
Autoinflammation: When is familial Mediterranean fever 'severe'?Helen J Lachmann, Paul A Brogan
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Best Practice & Research. Clinical Rheumatology|May 19, 2018
Periodic fever syndromesHelen J Lachmann
Journal of the American Society of Nephrology : JASN|May 15, 2024
Advancing Care for AA Amyloidosis with Biomarker-Based StagingHelen J Lachmann
Clinical Medicine (London, England)|June 3, 2015
Autoinflammatory syndromes as causes of fever of unknown originHelen J Lachmann
The New England Journal of Medicine|August 30, 2013
A new era in the treatment of amyloidosis?Helen J Lachmann
Current Allergy and Asthma Reports|July 6, 2011
The emerging role of interleukin-1β in autoinflammatory diseasesThirusha Lane, Helen J Lachmann
Clinical and Experimental Rheumatology|December 3, 2016
Reply to: Long-term tocilizumab efficacy in a patient with psoriatic arthritis and AA amyloidosis. Dinoia et alThirusha Lane, Helen J Lachmann
Rheumatic Diseases Clinics of North America|October 3, 2018
Secondary, AA, AmyloidosisRiccardo Papa, Helen J Lachmann
Turkish Journal of Medical Sciences|August 19, 2020
Familial Mediterranean fever, from pathogenesis to treatment: a contemporary reviewAbdurrahman Tufan, Helen J Lachmann
Current Opinion in Pharmacology|February 18, 2006
Systemic amyloidosisHelen J Lachmann, Philip N Hawkins
Nature Reviews. Rheumatology|April 26, 2016
Autoinflammation: When is familial Mediterranean fever 'severe'?Helen J Lachmann, Paul A Brogan
Pageof 22